GlassScriptPhysician profile
Chirag G Patel
NPI 1225290448
$1,008.63
in general payments reported to CMS, 2019-2025
15 companies · $64.32 in 2025
The $64.32 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $33.38 · 2021: $55.00 · 2022: $120 · 2023: $103 · 2024: $170 · 2025: $64.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $180.31 | 2019-2020 | |
| Alcon Vision LLC | $130.49 | 2022-2024 | Rocklatan, Clareon |
| Regeneron Healthcare Solutions, INC. | $115.13 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $103.36 | 2019 | |
| Allergan, INC. | $102.76 | 2019 | |
| Abbvie INC. | $87.36 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $65.75 | 2023-2025 | Envista Envy Iol, Sofport Ao |
| New World Medical,INC. | $58.29 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $40.67 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $29.10 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $24.56 | 2024 | Xdemvy |
| Teva Pharmaceuticals USA, INC. | $20.59 | 2024 | Austedo Xr |
| Mallinckrodt Hospital Products INC. | $19.67 | 2024 | Acthar |
| Sight Sciences, INC. | $16.19 | 2024 | Omni Surgical System |
| Horizon Therapeutics Plc | $14.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chirag Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.